Published in Antimicrob Agents Chemother on February 01, 1999
Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev (2007) 6.41
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida. Antimicrob Agents Chemother (2000) 2.33
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia. Antimicrob Agents Chemother (2001) 2.13
Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob Agents Chemother (2000) 1.87
Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol (2007) 1.70
In vitro and in vivo activities of posaconazole against Coccidioides immitis. Antimicrob Agents Chemother (2002) 1.42
Efficacy of SCH56592 in a rabbit model of invasive aspergillosis. Antimicrob Agents Chemother (2000) 1.25
Effects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers. Antimicrob Agents Chemother (2006) 1.22
Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS. Antimicrob Agents Chemother (2002) 1.14
Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model. Antimicrob Agents Chemother (2000) 1.10
Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection. Antimicrob Agents Chemother (2009) 1.00
Pathogenic differences between North American and Latin American strains of Histoplasma capsulatum var. capsulatum in experimentally infected mice. J Clin Microbiol (2004) 0.96
Posaconazole therapy of disseminated phaeohyphomycosis in a murine model. Antimicrob Agents Chemother (2004) 0.95
Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob Agents Chemother (2000) 0.90
Relationship of blood level and susceptibility in voriconazole treatment of histoplasmosis. Antimicrob Agents Chemother (2007) 0.82
Comparison of nikkomycin Z with amphotericin B and itraconazole for treatment of histoplasmosis in a murine model. Antimicrob Agents Chemother (2000) 0.81
Quantitative Microplate-Based Growth Assay for Determination of Antifungal Susceptibility of Histoplasma capsulatum Yeasts. J Clin Microbiol (2015) 0.79
Detection of Latin American strains of Histoplasma in a murine model by use of a commercially available antigen test. Clin Vaccine Immunol (2010) 0.78
Bats, fever and adenopathy - what is the link? Can J Infect Dis Med Microbiol (2013) 0.75
Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J Med Vet Mycol (1988) 3.24
In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrob Agents Chemother (1996) 3.20
In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Antimicrob Agents Chemother (1996) 3.08
Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group. Am J Med (1995) 2.63
Comparison of radioimmunoassay and enzyme-linked immunoassay methods for detection of Histoplasma capsulatum var. capsulatum antigen. J Clin Microbiol (1997) 2.37
Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis. Antimicrob Agents Chemother (1997) 2.07
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med (1992) 2.01
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1993) 1.82
Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations. Clin Infect Dis (1992) 1.58
Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrob Agents Chemother (1990) 1.54
Simplified bioassay method for measurement of flucytosine or ketoconazole. J Clin Microbiol (1985) 1.52
In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum. Antimicrob Agents Chemother (1990) 1.31
Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum. Antimicrob Agents Chemother (1997) 1.23
Local immunity in lung-associated lymph nodes in a murine model of pulmonary histoplasmosis. Infect Immun (1993) 1.00
Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis. Antimicrob Agents Chemother (1990) 0.99
Clearance of Histoplasma capsulatum variety capsulatum antigen is useful for monitoring treatment of experimental histoplasmosis. J Clin Lab Anal (1994) 0.93
Efficacy of the triazole D0870 in a murine model of systemic histoplasmosis. Antimicrob Agents Chemother (1995) 0.91
Nonfilamentous C. albicans mutants are avirulent. Cell (1997) 13.83
Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature (2001) 6.29
Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell (1992) 6.11
Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A (1986) 5.23
Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol (1988) 4.96
Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry (1998) 4.69
Why Americans eat what they do: taste, nutrition, cost, convenience, and weight control concerns as influences on food consumption. J Am Diet Assoc (1998) 4.65
Sexual orientation and suicidality: a co-twin control study in adult men. Arch Gen Psychiatry (1999) 3.97
Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes. Am J Epidemiol (1998) 3.66
A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch Gen Psychiatry (1993) 3.60
Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am J Med Genet (1996) 3.48
Determining zygosity in the Vietnam Era Twin Registry: an approach using questionnaires. Clin Genet (1989) 3.41
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother (2006) 3.25
Regional variation in the incidence of hip fracture. US white women aged 65 years and older. JAMA (1990) 3.18
The Vietnam Era Twin (VET) Registry: method of construction. Acta Genet Med Gemellol (Roma) (1987) 3.18
Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry (1999) 3.04
Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. HBO-CP Research Group. Lancet (2001) 2.79
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology (2012) 2.78
Bacitracin: Methods of Production, Concentration, and Partial Purification, with a Summary of the Chemical Properties of Crude Bacitracin. J Bacteriol (1948) 2.68
Race and sex differences in mortality following fracture of the hip. Am J Public Health (1992) 2.63
The Vietnam Era Twin Registry: a resource for medical research. Public Health Rep (1990) 2.53
Compliance with topical pilocarpine treatment. Am J Ophthalmol (1986) 2.48
Registry evaluation methods: a review and case study. Epidemiol Rev (1980) 2.45
Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry (2000) 2.38
Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes. J Virol (1987) 2.36
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida. Antimicrob Agents Chemother (2000) 2.33
Mealybug beta-proteobacterial endosymbionts contain gamma-proteobacterial symbionts. Nature (2001) 2.33
HTLV-I-induced lymphoma mimicking Hodgkin's disease. Diagnosis by polymerase chain reaction amplification of specific HTLV-I sequences in tumor DNA. Blood (1988) 2.30
What are American children eating? Implications for public policy. Nutr Rev (1995) 2.30
Preadmission anaesthesia consultation clinic. Can J Anaesth (1992) 2.27
Relationships between use of television during meals and children's food consumption patterns. Pediatrics (2001) 2.25
The expanded racial and ethnic codes in the Medicare data files: their completeness of coverage and accuracy. Am J Public Health (1996) 2.24
Mortality ascertainment in the veteran population: alternatives to the National Death Index. Am J Epidemiol (1995) 2.14
Imaging normal and abnormal brain development: new perspectives for child psychiatry. Aust N Z J Psychiatry (2001) 2.09
Hip fracture incidence among the old and very old: a population-based study of 745,435 cases. Am J Public Health (1990) 2.00
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592). J Antimicrob Chemother (2000) 1.98
Validity of the 'Ten Questions' for screening serious childhood disability: results from urban Bangladesh. Int J Epidemiol (1990) 1.95
Diagnosis of histoplasmosis by antigen detection during an outbreak in Indianapolis, Ind. Arch Pathol Lab Med (1994) 1.90
The heritability of alcoholism symptoms: "indicators of genetic and environmental influence in alcohol-dependent individuals" revisited. Alcohol Clin Exp Res (1999) 1.88
Differential heritability of adult and juvenile antisocial traits. Arch Gen Psychiatry (1995) 1.88
Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. J Immunol (1997) 1.87
Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob Agents Chemother (2000) 1.87
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc Natl Acad Sci U S A (2001) 1.79
Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol (1997) 1.78
A five-stage model for sustaining a community campaign. J Health Commun (2000) 1.76
Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect Immun (2001) 1.75
Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg (2008) 1.74
Interrelationship of genetic and environmental influences on conduct disorder and alcohol and marijuana dependence symptoms. Am J Med Genet (1999) 1.72
Hospitalization with vertebral fracture among the aged: a national population-based study, 1986-1989. Epidemiology (1992) 1.70
Subsequent sexually transmitted infection in urban adolescents and young adults. Arch Pediatr Adolesc Med (2001) 1.69
Five cases of calciphylaxis and a review of the literature. J Am Acad Dermatol (1999) 1.68
Elimination of false-positive Histoplasma antigenemia caused by human anti-rabbit antibodies in the second-generation Histoplasma antigen assay. Transpl Infect Dis (2006) 1.66
The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak. Ann Intern Med (1982) 1.65
Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother (1998) 1.65
Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys. Antimicrob Agents Chemother (2000) 1.64
Evaluation of cross-reactions in Histoplasma capsulatum serologic tests. J Clin Microbiol (1986) 1.58
Burnout and its correlates in emergency physicians: four years' experience with a wellness booth. Acad Emerg Med (1996) 1.56
Genetic and environmental contributions to smoking. Addiction (1997) 1.55
A cohort study of stomach cancer risk in men after gastric surgery for benign disease. J Natl Cancer Inst (1993) 1.55
SCH56592 treatment of murine invasive aspergillosis. J Antimicrob Chemother (1998) 1.55
Structure of the guanine nucleotide exchange factor Sec7 domain of human arno and analysis of the interaction with ARF GTPase. Cell (1998) 1.54
Genetic and environmental influences on posttraumatic stress disorder, alcohol and drug dependence in twin pairs. Drug Alcohol Depend (2000) 1.51
Post-traumatic migraine: chronic migraine precipitated by minor head or neck trauma. Headache (1991) 1.50
Activation in brain energy regulation and reward centers by food cues varies with choice of visual stimulus. Int J Obes (Lond) (2009) 1.50
A twin study of the association between pathological gambling and antisocial personality disorder. J Abnorm Psychol (2001) 1.49
Full robotic assistance for laparoscopic tubal anastomosis: a case report. J Laparoendosc Adv Surg Tech A (1999) 1.49
Epidemiologic uses of Medicare data. Epidemiol Rev (1993) 1.48
Dietary beta-carotene, vitamin C, and risk of prostate cancer: results from the Western Electric Study. Epidemiology (1996) 1.48
A registry-based twin study of depression in men. Arch Gen Psychiatry (1998) 1.45
Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis. Ann Intern Med (1982) 1.44
Seasonal variation in the incidence of hip fracture among white persons aged 65 years and older in the United States, 1984-1987. Am J Epidemiol (1991) 1.44
Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology (1983) 1.43
Contribution of emotionally traumatic events and inheritance to the report of current physical health problems in 4042 Vietnam era veteran twin pairs. Psychosom Med (1998) 1.42
Increased p53 staining in normal skin of posttransplant, immunocompromised patients and implications for carcinogenesis. Am J Dermatopathol (1999) 1.40
The striking differences in the prevalence of obesity by race. Obes Res (1994) 1.39
Immunohistochemical evaluation of androgen receptors in genital and extragenital lichen sclerosus: evidence for loss of androgen receptors in lesional epidermis. J Am Acad Dermatol (1999) 1.39
Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore) (1983) 1.39
Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a review of three consecutive trials of the treatment of poor prognosis patients. Leuk Res (1991) 1.38
Site-directed mutagenesis of amino acid residues of protein phosphatase 1 involved in catalysis and inhibitor binding. Proc Natl Acad Sci U S A (1997) 1.36
Discussion of preferences for life-sustaining care by persons with AIDS. Predictors of failure in patient-physician communication. Arch Intern Med (1993) 1.35
Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc Natl Acad Sci U S A (1993) 1.34
Reliability and validity of a combat exposure index for Vietnam era veterans. J Clin Psychol (1991) 1.33
Multiple cases of life-threatening adenovirus pneumonia in a mental health care center. Am J Respir Crit Care Med (1998) 1.32
Cutaneous epithelioid angioleiomyoma. Am J Dermatopathol (1998) 1.31
Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and cynomolgus monkeys. Antimicrob Agents Chemother (1984) 1.31
Pharmacokinetics and tissue penetration of Sch 39304 in granulocytopenic and nongranulocytopenic rabbits. Antimicrob Agents Chemother (1989) 1.30
Genetic and environmental influences on transitions in drug use. Behav Genet (1999) 1.29
Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol (1999) 1.29
Role of extracellular signal-regulated protein kinases in apoptosis by asbestos and H2O2. Am J Physiol (1997) 1.29
Antibiotic G418, a new micrommomospora-produced aminglycoside with activity apainst protozoa and helminths: antiparasitic activity. Antimicrob Agents Chemother (1975) 1.29
A twin study of generalized anxiety disorder symptoms, panic disorder symptoms and post-traumatic stress disorder in men. Psychiatry Res (2001) 1.28
Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression. Antimicrob Agents Chemother (1998) 1.27
Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study. Mod Pathol (2000) 1.26
Efficacy of SCH56592 in a rabbit model of invasive aspergillosis. Antimicrob Agents Chemother (2000) 1.25
Do genes influence exposure to trauma? A twin study of combat. Am J Med Genet (1993) 1.24
Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol (2001) 1.24
Felty syndrome. Semin Arthritis Rheum (1980) 1.22
Genetic and environmental influences on the relationship among combat exposure, posttraumatic stress disorder symptoms, and alcohol use. J Trauma Stress (2001) 1.22
Antigen and antibody testing for the diagnosis of blastomycosis in dogs. J Vet Intern Med (2008) 1.21